All News Aclarion, Inc.

Equities

ACON

US6551872012

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
0.3245 ^USD	-1.07%		+17.32%	-89.86%

26/02	Top Midday Decliners	MT
21/02	Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	25/04	AQ
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	04/03	AQ
Aclarion Announces Closing of $3.0 Million Public Offering	28/02	AQ
Top Midday Decliners	27/02	MT
Aclarion Announces Pricing of $3.0 Million Public Offering	26/02	AQ
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	05/02	AQ
Top Premarket Decliners	02/02	MT
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast	26/01	MT
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data	26/01	MT
Wall Street Set to Open Flat as Investors Eye Key Manufacturing Index	23/01	MT
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	22/01	AQ
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	17/01	AQ
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution	17/01	CI
Top Midday Gainers	09/01	MT
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	08/01	AQ
Aclarion and Atec Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	08/01	CI
Aclarion Announces Reverse Stock Split	02/01	AQ
Aclarion to Implement 1-for-16 Reverse Stock Split; Shares Rise	02/01	MT
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	27/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Aclarion, Inc.

Equities

ACON

US6551872012

All News

Filters